“…Most important, these include technical innovations in the late 1990s leading to the development of liquid-based cytology techniques, 9 cytology automation [1][2][3]12,13 and rigorous quality control measures to improve the reproducibility. 7,8,15,18,[21][22][23][24][25][26] As part of our systematic efforts to improve the quality of conventional Pap smear cytology, 21,22,25,27 we recently developed laboratory software (CONQUISTADOR) to assist this intraobserver and interlaboratory quality assurance, validated in a simulation study 28 and recently shown useful in a screening setting ongoing in Latin America (the LAMS study). 29 In addition to the discussed technical, classification and reproducibility issues, performance of Pap smear cytology in a screening setting also critically depends on the prevalence of the abnormalities (squamous intraepithelial lesion [SIL] and cervical cancer) in the target population.…”